On July 30, BrightSpring Health Services Inc. rose 5.07% in regular trading, trading at $72.96/share, with turnover of $85.12 million.

On the news front, the company is scheduled to release its second-quarter earnings before market open on July 31. Market consensus expects quarterly revenue of $3.658 billion, representing 22.34% year-over-year growth, with adjusted EPS of $0.40, up 132.20% year-over-year. Heading into the report, multiple investment banks have raised price targets in July: UBS lifted its target to $85 from $63 maintaining a Buy rating, Morgan Stanley raised to $80 from $71 keeping an Overweight rating, Guggenheim initiated coverage with a Buy rating and $81 target, and Raymond James initiated with an Outperform rating and $80 target.

The bullish sentiment follows a strong Q1 beat, where adjusted EPS of $0.39 exceeded the $0.31 consensus by 25.81%, and revenue of $3.614 billion topped the $3.392 billion estimate. The combination of accelerating earnings growth and clustered analyst upgrades ahead of the earnings release appears to be fueling optimism.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)